Which medication should NOT be included in the discharge plan for a myocardial infarction patient according to best practices?

In the context of managing a patient after a myocardial infarction (heart attack), incorporating best practices into the discharge plan is crucial for ensuring optimal recovery and preventing future cardiac events. Antibiotics are not typically warranted for patients post-myocardial infarction unless there is a specific coexisting infection that requires treatment. Their routine use can lead to unnecessary side effects, potential for antibiotic resistance, and is not part of the standard regimen aimed at improving cardiac outcomes.

In contrast, medications such as ACE inhibitors, dual antiplatelet therapy (DAPT), and high-intensity statins have been shown to play a significant role in secondary prevention, reducing mortality and morbidity by managing risk factors associated with cardiovascular disease. Using these medications aligns with established guidelines, while the routine use of antibiotics does not contribute positively to this goal in the context of a myocardial infarction discharge plan.